Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning

Bone Marrow Transplantation

Volumn 33, Issue 9, 2004, Pages 949-953

  Slatter, M A ^a   Gennery, A R ^a   Cheetham, T D ^a   Bhattacharya, T D ^a   Crooks, B N A ^a   Flood, T J ^a   Cant, A J ^a   Abinun, Mario ^a,b  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Hypothyroidism; Osteopetrosis; Primary immunodeficiency; Severe combined immunodefiency; Wiskott Aldrich syndrome

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; METHYLPREDNISOLONE; MICROSOME ANTIBODY; PREDNISOLONE; PREDNISONE; THYMOCYTE ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; GRAFT VERSUS HOST REACTION; HUMAN; HYPOTHYROIDISM; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; HYPOTHYROIDISM; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; OSTEOPETROSIS; THYROID GLAND; THYROXINE; TIME FACTORS; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION; WISKOTT-ALDRICH SYNDROME;

EID: 2442715230     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704456     Document Type: Article

References (29)

1. Buckley RH. Treatment options for genetically determined immunodeficiency. Lancet 2003; 361: 541-542.
2. Antoine C, Muller S, Cant A et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003; 361: 553-560.
3. Gennery AR, Dickinson AM, Brigham K et al. CAMPATH-1M T cell depleted bone marrow transplantation for severe combined immunodeficiency: long term follow up of 19 children treated in the period 1987-1998 in a single centre. Cytotherapy 2001; 3: 221-232.
4. Slatter MA, Bhattacharya A, Flood TJ et al. Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies. Bone Marrow Transplant 2003; 32: 225-229.
5. Katsanis E, Shapiro RS, Robison LL et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990; 5: 335-340.
6. Wedderburn LR, Jeffery R, White H et al. Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T and B cell repertoires, and evidence for reversion from the CD45RO+ to RA+ phenotype. Rheumatology 2001; 40: 1299-1307.
7. Al-Fiar FZ, Colwill R, Lipton JH et al. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants. Bone Marrow Transplant 1997; 19: 1019-1022.
8. Toubert M-E, Socie G, Gluckman E et al. Short and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preoperative total body irradiation. Br J Haematol 1997; 98: 453-457.
9. Kami M, Tanaka Y, Chiba S et al. Thyroid function after bone marrow transplantation: possible association between immune-mediated thyrotoxicosis and hypothyroidism. Transplantation 2001; 71: 406-411.
10. Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post bone marrow transplantation. Bone Marrow Transplant 1998; 22: 873-881.
11. Michel G, Socie G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation - a report from the Societe Francaise de greffe de moelle. J Clin Oncol 1997; 15: 2238-2246.
12. Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000; 25: 1087-1092.
13. Chapel H, Geha R, Rosen F, (IUIS PID classification committee). Primary immunodeficiency disease: an update. Clin Exp Immunol 2003; 132: 9-15.
14. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GvHD grading. Bone Marrow Transplant 1995; 15: 825-828.
15. Gluckberg H, Storb R, Fefer A et al. Clinical manifestations of GvHD in human recipients of marrow from HLA matched sibling donors. Transplant 1974; 18: 295-304.
16. Tauchmanova L, Selleri C, De Rosa G et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002; 95: 1076-1084.
17. Tunbridge WMG, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7: 481-493.
18. De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metabol 1999; 84: 151-164.
19. Karthaus M, Gabrysiak T, Brabant G et al. Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells. Bone Marrow Transplant 1997; 20: 697-699.
20. Devendra D, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol 2003; 111: s624-s36.
21. Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 2002; 99: 2694-2702.
22. Dupuis-Girrod S, Medioni J, Haddad E et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-centre cohort of 55 patients. Pediatrics 2003; 111: e622-e627.
23. Schurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 2003; 15: 446-453.
24. Olivares JL, Ramos FJ, Olive T et al. Autoimmune thyroiditis after bone marrow transplantation in a boy with Wiskott-Aldrich syndrome. J Pediatr Hematol/Oncol 2002; 24: 772-776.
25. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and x-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15: 430-435.
26. Kaino Y, Otoh Y, Tokuda K et al. Acquired hypothyroidism in a very young infant with Omenn's syndrome. J Pediatr 2000; 136: 111-113.
27. Trendelenburg M, Gregor M, Passweg J et al. 'Altered immunity syndrome', a distinct entity in long-term bone marrow transplantation survivors? Bone Marrow Transplant 2001; 28: 1175-1177.
28. Coles AJ, Wing M, Smith S et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1995; 354: 1691-1695.
29. Todd A, Todd J. Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin. Clin Lab Haem 1999; 21: 69-70.